Stemline Therapeutic (STML)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2009 | |
| Cash Flows From Operating Activities | |
| Net Income | -1,778 |
| Other Working Capital | 146 |
| Other Operating Activity | 71 |
| Operating Cash Flow | $-1,561 |
| Cash Flows From Investing Activities | |
| Change In Deposits | 8,600 |
| Investing Cash Flow | $8,600 |
| Cash Flows From Financing Activities | |
| Financing Cash Flow | $N/A |
| Beginning Cash Position | 2,197 |
| End Cash Position | 9,236 |
| Net Cash Flow | $7,040 |
| Free Cash Flow | |
| Operating Cash Flow | -1,561 |
| Free Cash Flow | -1,561 |